How many insider trades does FilingIQ track for MPLT?

FilingIQ tracks 144 Form 4 insider transactions for MPLT (MapLight Therapeutics, Inc.), covering filings from Oct 27, 2025 onwards. 85 of those were filed in the last 90 days.

Are MPLT insiders net buyers or net sellers?

Across the full Form 4 history for MPLT, 5 transactions (3%) were open-market purchases and 91 (63%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MPLT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MPLT in?

MapLight Therapeutics, Inc. (MPLT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $785.18M.

MPLT insider trading

Healthcare

MapLight Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

144

Last 90 days

Buys / sells

3% / 63%

Market cap

$785.18M

About MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. MapLight Therapeutics, Inc. was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California.

Company website: www.maplightrx.com

MPLT insider activity at a glance

FilingIQ has scored 144 insider transactions for MPLT since Oct 27, 2025. The most recent filing in our index is dated May 11, 2026.

Across the full history, 5 open-market purchases and 91 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MPLT insider trades is 51.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MPLT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MPLT?: FilingIQ tracks 144 Form 4 insider transactions for MPLT (MapLight Therapeutics, Inc.), covering filings from Oct 27, 2025 onwards. 85 of those were filed in the last 90 days.
Are MPLT insiders net buyers or net sellers?: Across the full Form 4 history for MPLT, 5 transactions (3%) were open-market purchases and 91 (63%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MPLT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MPLT in?: MapLight Therapeutics, Inc. (MPLT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $785.18M.

Methodology & sources

Every MPLT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.